Last updated: April 1, 2024
Sponsor: Taipei City Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Breast Cancer
Cancer
Treatment
Traditional Chinese Medicine Therapy Program for Reinforcing Vital Energy
Clinical Study ID
NCT06337214
TCHIRB-11301014-E
Ages 18-85 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Individuals aged 18 years and above and below 85 years, willing to voluntarilyparticipate in the study.
- Diagnosed with malignant breast tumors, ICD-10: C50, by conventional medicine.
- Patients currently undergoing cancer treatment, including chemotherapy, radiotherapy,or targeted therapy.
Exclusion
Exclusion Criteria:
- Diagnosed solely with carcinoma in situ or benign tumors, including fibrocystic breastconditions, by conventional medicine.
- Patients regularly receiving Astragalus polysaccharide injections.
- Patients with a history of allergies to Traditional Chinese Medicine.
- Pregnant or breastfeeding women.
- Individuals with a drug addiction habit, including both narcotic and non-narcoticdrugs.
- Any other situation where the participant is unable to cooperate (e.g., due to anyfactor that prevents participation, deemed unsuitable for participation by studystaff, unwillingness to sign the consent form).
Study Design
Total Participants: 80
Treatment Group(s): 1
Primary Treatment: Traditional Chinese Medicine Therapy Program for Reinforcing Vital Energy
Phase:
Study Start date:
March 13, 2024
Estimated Completion Date:
February 28, 2025
Study Description
Connect with a study center
Taipei City Hospital
Taipei, 10845
TaiwanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.